American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Washington, D.C.: American Psychiatric Association, 2013.
Amir N, Beard C, Cobb M, Bomyea J. Attention modification program in
individuals with generalized anxiety disorder. Journal of Abnormal Psychology
2009 February; 118(1): 28-33.
Arehart-Treichel J. Anxiety symptoms linked to women’s cardiac events.
Psychiatric News 2009 December; 44(24): 26-37.
Arehart-Treichel J. Extended GAD treatment keeps relapse rates low.
Psychiatric News 2011 February; 46(3): 24.
Baldwin D, Woods R, Lawson R, Taylor D. Efficacy of drug treatments for
generalized anxiety disorder: systematic review and meta-analysis. British
Medical Journal 2011 March; 342.
Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, et al. Consensus statement
on generalized anxiety disorder from the international consensus group on
depression and anxiety. Journal of Clinical Psychiatry 2001; 62(suppl 11):
53-58.
Beesdo K, Knappe S, Pine DS. Anxiety and anxiety disorders in children and
adolescents: developmental issues and implications for DSM-V. Psychiatric
Clinics of North America 2009 September; 32(3): 483-524.
Blumenthal H, Leen-Feldner EW, Babson KA, Gahr JL, Trainor CD, Frala JL.
Elevated social anxiety among early maturing girls. Developmental Psychology
2011 July; 47(4): 1133-1140.
Bystritsky A, Kerwin L, Feusner JD, Vapnik T. A pilot controlled trial of
buproprion XL vs. escitalopram in generalized anxiety disorder (GAD).
Pscychopharmacology Bulletin 2008; 41(1): 1-9.
Cuthbert B. Early prevention in childhood anxiety disorders.
American Journal
of Psychiatry 2010; 167:1428-1430.
Fava M, Asnis GM, Shrivastava R, Lydiard B, et al. Zolpidem extended-release
improves sleep and next-day symptoms in comorbid insomnia and generalized
anxiety disorder. Journal of Clinical Psychopharmacology 2009 June; 29(3):
222-230.
Flint A, Peasley-Miklus C, Papademetriou E, et al. Effect of age on the
frequency of anxiety disorders in major depression with psychotic features.
American Journal of Geriatric Psychiatry 2010 May; 18 (5): 404-412.
Grant BF, Hasin DS, Blanco C, Stinson FS, et al. The epidemiology of social
anxiety disorder in the United States: results from the national epidemiologic
survey on alcohol and related conditions. Journal of Clinical Psychiatry 2005
November; 66(11): 1351-1361.
Hammond DC. Hypnosis in the treatment of anxiety- and stress-related
disorders. Expert Review of Neurotherapy 2010 February; 10(2): 263-273.
Herring MP, O’Connor PJ, Dishman RK. The effect of exercise training on
anxiety symptoms among patients: a systemic review. Archives of Internal
Medicine 2010 February; 170(4): 321-331.
Johnson JG, Cohen P, Pine DS, et al. Association between cigarette smoking
and anxiety disorders during adolescence and early adulthood. Journal of the
American Medical Association 2000; 284: 2348-2351.
Kalra SK, Swedo SE. Children
with obsessive-compulsive disorder: are they just “little adults?” Journal of
Clinical Investigation 2009; 119(4): 737-746.
Merikangas KR, He JP, Brody D,
Fisher PW, et al. Prevalence and treatment of mental disorders among U.S.
children in the 2001-2004 NHANES. Pediatrics 2010 January; 125(1): 75-81.
McLaughlin KA, Hatzenbuehler ML. Stressful life events, anxiety sensitivity,
and internalizing symptoms in adolescents. Journal of Abnormal Psychology 2009
August; 118(3): 659-669.
Nasreen HE, Kabir ZN, Forsell Y, Edhborg M. Low birth weight in offspring of
women with depressive and anxiety symptoms during pregnancy: results from a
population based study in Bangladesh. Biomed Central Public Health 2010; 10:
515.
Pande AC, Pollack MH, Crockatt J, Greiner M, Chouinard G, et al.
Placebo-controlled study of gabapentin treatment of panic disorder. Journal of
Clinical Psychopharmacology 2000 August; 20(4): 467-471.
Piacentini J, Roblek T.
Recognizing and treating childhood anxiety disorders. Western Journal of
Medicine 2002 May; 176(3): 149-151.
Pincus DB, May JE, Whitton SW, Mattis SG,
Barlow DH. Cognitive-behavioral treatment of panic disorder in adolescence.
Journal of Clinical Child and Adolescent Psychology 2010 Sep; 39(5):
638-49.
Rapee RM. The development and modification of temperamental risk for
anxiety disorders: prevention of a lifetime of anxiety? Biological Psychiatry
2002 November; 52(10): 947-957.
Rickels K, Pollack MH, Sheehan DV, Haskins JT. Efficacy of extended-release
venlafaxine in nondepressed outpatients with generalized anxiety disorder.
American Journal of Psychiatry 2000; 157: 968-974.
Saeed SA, Bloch RM, Antonacci
DJ. Herbal and dietary supplements for treatment of anxiety disorders. American
Family Physician 2007 Aug 15; 76(4): 549-56.
Soto JA, Dawson-Andoh NA, BeLue R.
The relationship between perceived discrimination and generalized anxiety
disorder among African Americans, Afro Caribbeans and non-Hispanic Whites.
Journal of Anxiety Disorders 2011 March; 25(2): 258-265.
Trivedi JK, Gupta PK. An overview of Indian research in anxiety disorders.
Indian Journal of Psychiatry 2010; 52(7): 210-218.
White SW, Ollendick T, Scahill L, Oswald D, Albano AM. Preliminary efficacy
of a cognitive-behavioral treatment program for anxious youth with autism
spectrum disorders. Journal of Autism and Developmental Disorders 2009 June.